Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Retained Earnings (2016 - 2025)

Mimedx's Retained Earnings history spans 15 years, with the latest figure at -$42.7 million for Q4 2025.

  • For Q4 2025, Retained Earnings rose 53.23% year-over-year to -$42.7 million; the TTM value through Dec 2025 reached -$42.7 million, up 53.23%, while the annual FY2025 figure was -$42.7 million, 53.23% up from the prior year.
  • Retained Earnings for Q4 2025 was -$42.7 million at Mimedx, up from -$57.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$42.7 million in Q4 2025 and bottomed at -$196.9 million in Q1 2023.
  • The 5-year median for Retained Earnings is -$160.7 million (2021), against an average of -$139.0 million.
  • The largest annual shift saw Retained Earnings tumbled 49.41% in 2021 before it soared 53.23% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$161.7 million in 2021, then decreased by 18.67% to -$191.9 million in 2022, then soared by 30.34% to -$133.7 million in 2023, then skyrocketed by 31.73% to -$91.3 million in 2024, then skyrocketed by 53.23% to -$42.7 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Retained Earnings are -$42.7 million (Q4 2025), -$57.9 million (Q3 2025), and -$74.6 million (Q2 2025).